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Abstract
Emerin is an integral membrane protein of the inner nuclear membrane. Mutations in emerin cause X-linked Emery-Dreifuss
muscular dystrophy (EDMD), a disease characterized by skeletal muscle wasting and dilated cardiomyopathy. Current
evidence suggests the muscle wasting phenotype of EDMD is caused by defective myogenic progenitor cell differentiation
and impaired muscle regeneration. We obtained genome-wide expression data for both mRNA and micro-RNA (miRNA) in
wildtype and emerin-null mouse myogenic progenitor cells. We report here that emerin-null myogenic progenitors exhibit
differential expression of multiple signaling pathway components required for normal muscle development and
regeneration. Components of the Wnt, IGF-1, TGF-b, and Notch signaling pathways are misexpressed in emerin-null
myogenic progenitors at both the mRNA and protein levels. We also report significant perturbations in the expression and
activation of p38/Mapk14 in emerin-null myogenic progenitors, showing that perturbed expression of Wnt, IGF-1, TGF-b,
and Notch signaling components disrupts normal downstream myogenic signaling in these cells. Collectively, these data
support the hypothesis that emerin is essential for proper myogenic signaling in myogenic progenitors, which is necessary
for myogenic differentiation and muscle regeneration.
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Introduction
The nucleus is the primary site of nucleic acid regulation,
including DNA replication, RNA transcription, and the organi-
zation of active and repressed chromatin domains. Proper
regulation of these processes is essential for successful lineage
specification and differentiation during embryonic development
and for tissue repair after injury. Thus, these processes must be
tightly controlled to ensure that the appropriate repertoire of genes
is expressed during specification and differentiation into particular
cell types.
The nucleus is separated from the cytosol by the nuclear
envelope, which is composed of two lipid bilayers: the outer
nuclear membrane (ONM), which is contiguous with the
endoplasmic reticulum, and the inner nuclear membrane (INM).
Underlying the INM is a meshwork of type V intermediate
filament proteins called lamins, which are the major scaffolding
component of the nuclear lamina [1]. The INM contains greater
than 70 integral INM proteins, many of which bind directly to
lamins. Collectively the INM proteins and lamins are referred to as
the nuclear lamina. The nuclear lamina provides the nuclear
envelope with the elasticity necessary to maintain proper nuclear
structure under high stress loads [2] (e.g., contracting muscle).
Lamins are also required for proper localization of many INM
proteins to the nuclear envelope [3].
Emerin was one of the first INM proteins to be discovered
[4,5,6] and is a founding member of the LEM-domain family of
proteins that includes Lap2b, Emerin, and MAN1 [7]. Mutations
in emerin cause X-linked Emery-Dreifuss Muscular Dystrophy
(EDMD), a disease characterized by skeletal muscle wasting and
irregular heart rhythms. The skeletal muscle phenotypes of
EDMD have been attributed to an inability to regenerate
damaged muscle [8,9]. Emerin is expressed in all differentiated
cells, yet emerin loss affects only skeletal muscle, heart and
tendons. Thus emerin was proposed to have roles in regulating
tissue-specific gene expression or cell signaling pathways. Several
groups have investigated signaling disruptions in cells containing
mutations in emerin or lamin A that are associated with EDMD.
ERK1/2 is upregulated in emerin-null [10] and lamin A H222P
mutant mouse [11] hearts. Importantly, downstream target genes
were also misregulated showing that ERK signaling was disrupted
in these mice [11]. Interestingly, some phenotypes in these mice
could be relieved by treatment with the ERK inhibitor PD98059
[12]. C2C12 myoblasts and HeLa cells downregulated for emerin
or lamin A also had perturbed ERK signaling [12]. Skeletal
muscle from EDMD patients and emerin-null mice also exhibit
increased expression of Rb-MyoD pathway components including
CBP and p300 [8,9] and prolonged phosphorylation of Rb1 [8],
which was associated with delayed MyoD activity and impaired
skeletal muscle regeneration.
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differentiated myofibrils. Peripheral to these fibers is a niche
populated by muscle stem cells called satellite cells or myogenic
progenitors. Upon muscle damage quiescent satellite cells become
activated. These activated satellite cells then asymmetrically divide
to repopulate the niche and generate transient-amplifying
myoblasts, which proliferate rapidly [13]. These myoblasts then
differentiate into committed myocytes, which complete regener-
ation by fusing with the damaged myofibrils to repair the damaged
skeletal muscle.
Several signaling pathways are important for muscle differen-
tiation and regeneration, including the TGF-b [14], Wnt [15,16],
Notch [17], and IGF [18,19,20] pathways. An isoform of IGF-1
was shown to promote hypertrophy in adult mouse muscle
through stimulating both muscle progenitor cell proliferation and
enhanced differentiation of committed myoblasts [21]. During
early myogenesis, high levels of IGF-1 increased expression of cell
cycle promoting genes, including cyclins, and decreased expression
of myotube specification genes, such as myogenin [22]. This was
followed by decreased expression of cell cycle genes and increased
expression of myogenesis promoting factors later in myogenesis
[22]. Cells lacking a functioning IGF-1 receptor (IGF1R) show
decreased expression of proliferation markers, including Ki67, and
form fewer myotubes in culture [23,24].
TGF-b-family signaling inhibits muscle development and
regeneration, with inhibitory effects on both satellite cell recruit-
ment and myoblast differentiation [25]. Addition of TGF-b1i n
murine and human cell culture of C2C12 myoblasts blocked
IGF1R signaling and inhibited IGF-II expression and excretion,
resulting in the inhibition of muscle differentiation and muscle
repair [26]. Decreased expression of important differentiation
factors correlates with increased expression of myogenic progen-
itor proliferation factors in murine myoblasts treated with TGF-b
[27].
Notch expression is upregulated in activated satellite cells and
Notch signaling promotes satellite cell differentiation and in-
creased numbers of proliferative myogenic progenitor cells.
Addition of the constitutively active Notch intracellular domain
was shown to repress initiation of the myogenic program by
inactivating MyoD [28]. After differentiation into myogenic
progenitor cells, high levels of Notch act to prevent further
differentiation [17]. Further, actively dividing cells with high levels
of Notch signaling were shown to retain their undifferentiated
myogenic progenitor identity [17]. Decreased Notch signaling was
also associated with muscle hypotrophy and loss of regeneration
potential [29]. Thus Notch signaling is hypothesized to be integral
for maintaining the satellite cell niche and myogenic progenitor
cells.
Notch and Wnt signaling are temporally coordinated to ensure
proper differentiation, as these pathways promote proliferation
and differentiation, respectively. A switch from Notch to Wnt
signaling is necessary during adult myogenesis [30]. Wnts and
their downstream effector, b-catenin, promote progression from
satellite cells to myotubes [31]. However, excessive Wnt signaling
during aging ceases to be pro-myogenic and instead leads to
increased muscular fibrosis [31], showing that inappropriate Wnt
signaling during myogenesis is highly disruptive. In Wnt3a treated
myoblasts, high levels of activated b-catenin are associated with
differentiating but not proliferating cells [30]. Wnt3a has also been
shown to promote myoblast fusion, an important step in myotube
formation and muscle regeneration [32]. Frizzled7 and its related
ligand Wnt7a were also shown to promote skeletal muscle
regeneration by supporting the symmetric division of satellite
cells, thereby increasing the pool of cells available for differenti-
ation [33]. Interestingly, emerin was shown to interact with b-
catenin and prevent its accumulation in the nucleus [34],
suggesting that emerin regulates Wnt signaling in the myogenic
lineage. Thus, we predict emerin-null myogenic progenitors will
exhibit significantly perturbed Wnt signaling.
The importance of micro-RNAs (miRNAs), ,22 nucleotide
non-coding RNAs, as regulators of diverse cellular processes
including development and differentiation has become evident in
recent years [35]. miRNAs generally act by binding mRNAs at
their 39 UTR in the cytoplasm and degrading them or attenuating
their rate of translation. Thus miRNAs are hypothesized to fine
tune gene expression, which is crucial for regulating developmen-
tal pathways [36]. Several myogenic miRNAs (myomiRs) have
been described as being particularly important in heart and
skeletal muscle development, including miR-206 [37]. Myogenic
regulatory factors Myf5 and Myogenin activate the expression of
both miR-1 and miR-206, while MyoD is capable of activating
only the expression of miR-206 [38]. miR-1 and miR-206
expression is upregulated early during myogenic differentiation
and downregulated during regeneration in injured muscle [39].
miR-1 and miR-206 target Pax7 and regulate its expression [39].
Thus the coordinated expression of miR-1 and miR-206 is
important for modulating the balance between proliferation and
differentiation by directly regulating Pax7 [39]. miR-486 also
regulates Pax7 expression and a miR-resistant form of Pax7 causes
defective differentiation in myoblasts [40]. miR-221 and miR-222
are downregulated upon differentiation of proliferating myoblasts,
then upregulated in terminally differentiated myotubes [41].
Ectopic expression of miR-221 and miR-222 are capable of
disrupting early myogenesis and terminal myotube differentiation
[41]. During myogenic differentiation, MyoD directly increases
production of miR-378, which enhances MyoD activity by
repressing the anti-myogenic protein MyoR [42]. miR-125b
negatively regulates IGF-II expression, with excess levels acting
to inhibit myoblast differentiation and muscle regeneration [43].
miR-181 is necessary for differentiation of myoblasts, with one of
its targets being the myoblast differentiation repressor Hox-A11
[44]. miR-24 is upregulated during myoblast differentiation, and
its expression is repressed by TGF-b1 in a Smad3-dependent
manner [45].Though inroads have been made into the function of
miRNAs in myogenesis, to date a complete picture of the miRNA-
regulatory landscape in the myogenic lineage remains elusive.
Further, changes in miRNA expression have only been deter-
mined in selected forms of muscular dystrophy models of
Duchenne muscular dystrophy [46,47,48,49]. It remains to be
determined if miRNA expression changes in other forms of
muscular dystrophy and how this may affect the transcriptome of
skeletal muscle. Further, it will be important to determine how
miRNA expression changes during satellite cell differentiation and
muscle regeneration and how these expression changes are altered
during differentiation and regeneration of dystrophic muscle.
To elucidate molecular pathways implicated in the EDMD
disease mechanism, we performed mRNA and miRNA expression
profiling in emerin-null myogenic progenitors. Emerin-null
myogenic progenitors were used because the skeletal muscle
phenotype of EDMD is predicted to be caused by the failure of
myogenic progenitors to differentiate properly and regenerate
damaged muscles [8,9,50]. Although gene expression profiling has
been performed in muscle from patients and mice, these tissues are
a heterogeneous population of cells containing fully differentiated
cells, muscle stem cells, myogenic progenitors, fibroblasts and
immune infiltrate. Thus the use of cultured myogenic progenitors
has significant advantages over whole tissue analysis. We found
that several components of the Notch, Wnt, TGF-b, and IGF
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stream targets of these pathways were also misexpressed at both
the transcriptional and translational level. Phosphorylation of p38,
a key component of these signaling pathways, was also altered in
emerin-null myogenic progenitors. Perturbations in all four
pathways suggest that the loss of emerin has significant effects
on myogenic signaling in murine myogenic progenitors.
Results
Gene Expression Profiling of Emerin-null Myogenic
Progenitors
We performed whole genome mRNA microarray analysis on
proliferating wildtype and emerin-null H2K myogenic progenitors
to determine how myogenic gene expression was affected by
emerin loss. H2K myogenic progenitors were used for this analysis
because myogenic progenitors derived from emerin-null H2K
mice are superior to the C2C12 myoblast-derived cell line in many
ways. For example, decades in cell culture have caused C2C12
myoblasts to diverge significantly from the myoblasts they were
derived from and are aneuploid for multiple chromosomes.
Emerin-null H2K myogenic progenitors conditionally express
the SV40 large-T antigen, which allows primary cells derived from
these mice to be passaged directly for multiple generations without
losing their progenitor identity [51,52]. H2K myogenic progen-
itors can be efficiently induced to differentiate into myotubes upon
serum withdrawal.
RNA was isolated from 500,000 wildtype or emerin-null
myogenic progenitors and hybridized to Affymetrix Mouse Whole
Genome 430 2.0 microarrays (n=2). The microarray data is
available through the NCBI Gene Expression Omnibus and
accessible through GEO accession numbers GSM787509–
GSM787512. This analysis showed extensive differences in gene
expression between wildtype and emerin-null myogenic progen-
itors, as 13.3% of genes (p,0.05, fold-change .1.5) showed
perturbed expression in emerin-null H2K myogenic progenitors.
QVALUE software developed by Alan Dabney and John Storey
was then used to increase the confidence in these results. Using this
approach we found that a p-value ,0.035 was required to obtain a
False Discovery Rate (FDR) of 5%. Applying this threshold to our
data results in 2792 genes out of 21804 unique transcripts (12.5%)
altering mRNA expression by greater than 1.5-fold in emerin-null
H2K myogenic progenitors. mRNA with altered expression in
emerin-null myogenic progenitors included components of the
CREBBP/p300 transcriptional pathway, including CREBBP,
Ep300 and Kat2b (Figure 1C). Studies previously found perturbed
expression of components of the CREBBP/p300 transcriptional
pathway in emerin-null human [9] and mouse [8] skeletal muscle.
Emerin-null skeletal muscle and emerin ablation in myoblasts also
altered the expression of MyoD [8,50], an essential myogenesis
promoting factor. We also recently showed altered MyoD
expression in emerin-null myogenic progenitors [53].
Gene Networks Affected by Loss of Emerin Include
Components of Signaling Pathways that Regulate
Myogenic Progenitor Proliferation and Differentiation
Microarray expression data was analyzed with Ingenuity
software to identify gene networks and pathways significantly
affected by loss of emerin. This analysis showed there was
significant perturbation of signaling pathways previously shown to
be important for regulating myogenic differentiation, including
Notch, Wnt, TGF-b, and IGF (Figure 1; Figure S1, S2, S3, S4).
We found the Notch pathway components Dll1 (1.74-fold) and
Gsk3b (1.45-fold) were upregulated in emerin-null myogenic
progenitors, while Ckn1b (0.64-fold), Rbpj (0.63-fold), Mapkapk3
(0.59-fold), Numb (0.59-fold), Adam12 (0.52-fold), Ccnd1 (0.48-fold),
Mapk14/p38 (0.32-fold), Adam10 (0.24-fold), and Adam17 (0.20-
fold) were downregulated (Figure 1A). Downregulation of these
genes suggests Notch signaling is attenuated in emerin-null
progenitors. However, the Notch antagonist numb is also down-
regulated, suggesting compensatory changes in expression of
Notch pathway inhibitors may result in normal Notch signaling in
the absence of emerin.
Expression of Wnt pathway components was also altered in
emerin-null myogenic progenitors (Figure 1B). Wnt pathway genes
Wnt5a (3.53-fold), Wisp1 (1.63-fold), Sfrp1 (1.59-fold), Wnt5b (1.5-
fold), and Fzd3 (1.3-fold) were all upregulated. Wnt pathway
transcripts Wnt4 (0.85-fold), Fzd4 (0.82-fold), Rhou (0.80-fold), Dvl2
(0.80-fold), Fzd7 (0.77-fold), Dvl1 (0.75-fold), Sfrp2 (0.66-fold), Fzd2
(0.61-fold), Fzd1 (0.54-fold), Fzd6 (0.41-fold), and Fbxw2 (0.33-fold)
were downregulated. Decreased expression of several Wnt
receptors suggests that Wnt signal transduction may be impaired
in emerin-null myogenic progenitors.
Expression of TGF-b pathway components was altered in
emerin-null myogenic progenitors (Figure 1C). Tgfb2 (2.89-fold),
Foxo1 (1.84-fold), Tgfb1i1 (1.57-fold), Serpine1 (1.53-fold), Ep300/
p300 (1.31-fold) and Tgfbr1 (1.28-fold) were upregulated. Tgfbr2
(0.85-fold), Tgfbr3 (0.82-fold), Col3a1 (0.76-fold), Kat2b/PCAF
(0.73-fold), Stat1 (0.65-fold), Crebbp/CBP/p300 (0.62-fold), Col1a2
(0.55-fold), Pdgfb (0.48-fold), Bmp1 (0.37-fold), and Acvr1 (0.3-fold)
were downregulated. These results suggest that TGF-bsignaling is
attenuated in emerin-null myogenic progenitors, resulting in
impaired activation of downstream target genes.
Emerin-null myogenic progenitors exhibit altered expression of
IGF pathway genes (Figure 1D). Igfbp2 (13.11-fold), Igf2bp3 (6.25-
fold), Igf1 (4.42-fold), Igfbp3 (2.7-fold), Igfbp4 (2.5-fold), Igf2bp1
(2.04-fold), Igf2 (1.83-fold), Igfbp5 (1.61-fold), Igf2bp2 (1.59-fold),
Igf1r (1.57-fold) and Igf2r (1.46-fold) were upregulated. Igfbp6 (0.77-
fold) and Igfbp7 (0.39-fold) were downregulated. While Igf1 and
Igf2 are upregulated, numerous IGF-binding proteins appear to be
concomitantly upregulated, suggesting emerin-null progenitors are
attempting to compensate for increased IGF signaling. From this
expression data it cannot be predicted whether IGF signaling is
disrupted in emerin-null myogenic progenitors.
Validation of Selected Pathway Components
Quantitative RT-PCR (qPCR) was used to validate 49
components of the Notch, Wnt, TGF-b, and IGF signaling
pathways. Supporting the microarray results, we found the Notch
pathway component Rbpj (1.9-fold) was upregulated and Notch,
Gsk3b (0.78-fold), Mapk14/p38 (0.73-fold), Ccnd1 (0.69-fold),
Mapkapk3 (0.46-fold) and Cdkn1b (0.29-fold) were downregulated
(Figure 2A). Wnt pathway components Wnt11 (5.45-fold), Wnt5b
(2.56-fold), Frzb (1.98-fold), and Wisp1 (1.5-fold) were upregulated
in emerin-null myogenic progenitors (Figure 2B). Emerin-null
progenitors had decreased expression of Fzd1 (0.38-fold), Fzd5
(0.63-fold), Fzd6 (0.58-fold), Fzd7 (0.47-fold), Wnt2b (0.44-fold),
Wnt4 (0.27-fold) and Wnt6 (0.19-fold). Components of the TGF-b
and IGF pathways were also validated by qPCR, as Igfbp3 (5.27-
fold), Igfbp5 (2.78-fold), Igf1 (3.3-fold), Tgfbr1 (1.96-fold), Foxo1
(2.01-fold) and Ep300/p300 (1.81-fold-fold) were upregulated and
Tgfbr2 (0.6-fold), Crebbp/CBP/p300 (0.54-fold), Bmp1 (0.54-fold),
Kat2b/PCAF (0.37-fold) and Tgfbr3 (0.02-fold) were downregulated
(Figure 2C).
GFP-emerin or GFP was expressed in emerin-null myogenic
progenitors and Gsk3b, Mapk14 and Igfbp3 expression was
measured to test if emerin was directly responsible for their
altered gene expression. Emerin was overexpressed 601-fold,
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seen in emerin-null myogenic progenitors (839-fold). mRNA levels
were normalized to Gapdh expression. Changes in Gsk3b, Mapk14
and Igfbp3 mRNA expression were determined by comparing their
expression in GFP-emerin expressing cells to GFP transfected cells.
Importantly, expression of GFP-emerin increased the expression
of Gsk3b (3.5561.5 fold) and Mapk14 (1.5660.35 fold) and
decreased Igfbp3 expression (0.6560.2 fold) in emerin-null cells
(Figure 2G). Thus loss of emerin is directly responsible for altered
expression of Gsk3b, Mapk14 and Igfbp3 in emerin-null cells.
Kat2b and GSK3b protein levels were then measured to
confirm changes in mRNA expression resulted in decreased
protein expression. Cell lysates from wildtype and emerin-null
myogenic progenitors were separated by SDS-PAGE, transferred
to nitrocellulose and western blotted for Kat2b, GSK3b and c-
tubulin. c-tubulin was the loading control. Densitometry was used
to determine Kat2b and GSK3b protein expression. Importantly,
GSK3b and Kat2b protein expression was reduced 0.5660.12
fold (n=5; Figure 2D,E) and 0.6660.07 fold (n=4; Figure 2D,F),
respectively. Thus, reduced Kat2b and GSK3b mRNA expression
results in reduced Kat2b and GSK3b protein expression.
It was formally possible that conditional expression of the Large
T-antigen in the H2K myoblasts was responsible for the altered
expression of these signaling components. Primary myoblasts were
derived from wildtype C57BL/6 and protein levels of Myf5,
GSK3b and Kat2b were measured to test if their expression was
altered in H2K myoblasts. Whole cell lysates of primary myoblasts
and wildtype H2K myoblasts were separated by SDS-PAGE and
western blotted for Myf5, Kat2b, GSK3b and c-tubulin.
Importantly, there was no difference in expression of Myf5,
GSK3b and Kat2b between primary myoblasts and wildtype H2K
myoblasts (Figure S5).
To determine whether changes in expression of Notch, IGF-1,
TGF-b or Wnt pathway components affected downstream
signaling, we measured the expression of selected target genes
within these pathways. Importantly, we found significant changes
in the expression of downstream Wnt targets, including Lef1 (1.94-
fold), Ppp2r1a (0.81-fold), Dlv2 (0.74-fold), Fbxw2 (0.74-fold),
Ctnnbip1 (0.73-fold), Lrp5 (0.73-fold), Ctbp1 (0.66-fold), Dvl1 (0.62-
fold), Porcn (0.59-fold), Rhou (0.48-fold), and Sfrp2 (0.39-fold;
Figure 3A). Decreased activation of these Wnt target genes is
consistent with attenuation of Wnt signaling in emerin-null
myogenic progenitors.
Changes in expression of TGF-b pathway components in
emerin-null myogenic progenitors also altered the expression of
target genes, including Serpine1 (2.15-fold), Inha (2.04-fold), Stat1
(0.42-fold), Col3a1 (0.28-fold), Col1a2 (0.26-fold), Gdf6 (0.26-fold),
Pdgfb (0.26-fold), Itgb7 (0.13-fold), and Acvr1 (0.11-fold; Figure 4b).
These results show that emerin-null progenitors have attenuated
TGF-b signaling, as a majority of these target genes were
Figure 1. mRNA expression profiling identifies changes in Notch, Wnt, TGF-b and IGF pathways. mRNA microarray expression data from
emerin-null myogenic progenitors was normalized to mRNA expression in wildtype progenitors. Dotted line represents no change in expression. A)
Notch pathway. B) Wnt pathway. C) TGF-b pathway. D) IGF pathway. All changes in gene expression were statistically significant (p#0.05).
doi:10.1371/journal.pone.0037262.g001
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expression of certain TGF-b signaling components or target genes
may reflect a mechanism for these cells to attempt to compensate
for decreased TGF-b signaling.
Emerin-null Myogenic Progenitors Show Disrupted
miRNA Expression
We next examined miRNA expression in wildtype and emerin-
null myogenic progenitors, as miRNA expression profiling had
never been examined in emerin-null skeletal muscle or isolated
myogenic progenitors. miRNAs are often contained within RNA
polymerase II transcripts and thus we predicted emerin-null
progenitors would exhibit changes in miRNA expression. To
determine if emerin-null myogenic progenitors had disrupted
miRNA expression, we performed miRNA expression analysis
using Affymetrix Genechip miRNA microarrays. The microarray
data is accessible through GEO accession numbers GSM787505-
GSM787508. Though the Genechip miRNA array contains
probes for all known miRNAs across multiple species, we chose
to limit our analysis to the 609 mouse miRNAs, as sequence
homology between miRNAs of different species is an imperfect
predictor of shared targets. Of the mouse miRNAs on the chip, 47
showed altered expression levels in emerin-null progenitors
(p,0.05), representing 7.7% of all known murine miRNAs. We
Figure 2. Validation of selected components of the Notch, Wnt, TGF-b and IGF pathways. Validation of mRNA expression changes of
selected Notch, Wnt, TGF-b and IGF pathways by qPCR. Dotted line represents no change in expression. A) Notch and p38 components. B) Wnt
components. C) IGF and TGF-b components. All changes in gene expression were statistically significant (p#0.05). D) Whole cell lysates of wildtype
and emerin-null H2K myogenic progenitors were separated by SDS-PAGE and western-blotted for GSK3b, Kat2b and c-tubulin. E,F) Densitometry was
performed on blots in panel D and GSK3b and Kat2b levels were normalized to c-tubulin. Emerin-null protein expression was normalized to protein
expression in wildtype progenitors. G) GFP-emerin or GFP was expressed in emerin-null cells and Gsk3b, Mapk14, Igfbp3 and Gapdh were measured by
qPCR. Data is depicted as fold-change in GFP-emerin expressing cells compared to GFP-transfected cells.
doi:10.1371/journal.pone.0037262.g002
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mRNA targets. Interestingly, many of these miRNAs are predicted
to target myogenic signaling components, some of which also
showed aberrant mRNA expression (Table 1).
Of particular note are some of the most highly dysregulated
miRNAs, including miR-183 (3.25-fold), miR-100 (1.97-fold),
miR-713 (1.92-fold), miR-199a-5p (1.8-fold), miR-207 (1.74-fold),
miR-132 (0.17-fold), miR-192 (0.39-fold), miR-195 (0.40-fold),
miR-297a* (0.42-fold) and miR-298 (0.45-fold; Figure 4). Impor-
tantly, these are predicted to target important signaling compo-
nents in the Notch, Wnt, TGF-b, and IGF pathways (Table 1).
While several of the hits from our mRNA microarray studies
appear to also be targets of post-transcriptional regulation,
including Igf1, Igf2, Inha, Igfbp5, Fzd3, Wnt10a, Rbpj and
Mapk14, we also report here several interesting putative miRNA
targets that may have disrupted protein expression in the absence
of emerin, including Lamin B1, the insulator protein CTCF, and
HDAC3.
Decreased expression of miR-298 and miR-195 is predicted to
result in increased protein expression of Myf5 and Smad2,
respectively, in emerin-null myogenic progenitors. Our previous
work showed that MyoD and Myf5 were upregulated in emerin-
null myogenic progenitors [53]. Myf5 and MyoD expression was
rescued by exogenous expression of emerin in these emerin-null
progenitors. Western blotting was performed on wildtype and
emerin-null myogenic progenitors to confirm Myf5 and Smad2
expression was increased in emerin-null myogenic progenitors.
Myf5 and Smad2 protein levels were normalized to c-tubulin
levels. Confirming our previous results, Myf5 protein levels
increased 1.8260.22 fold (n=5) in emerin-null myogenic progen-
itors (Figure 5A,B). Smad2 protein levels increased 1.6860.3
(n=4; Figure 5A,C). Thus, reduction of miR-298 and miR-195
results in increased expression of their predicted targets.
Upregulation of miR-713 is likely to lead to decreased p38
protein and a diminished ability of emerin-null myogenic
progenitors to respond to external p38 activation stimuli, since
miR-713 is predicted to target Mapk14/p38. This is significant
because recent evidence shows p38 is directly responsible for
repression of Pax7 after satellite cell expansion during muscular
regeneration [54,55]. To test if Mapk14/p38 protein levels are
decreased in emerin-null myogenic progenitors we performed
western blotting on wildtype and emerin-null progenitor cell
lysates using antibodies against Mapk14/p38 (Figure 6A). Emerin-
null myogenic progenitors exhibit 0.65-fold expression of
Figure 3. Downstream target genes of the Wnt and TGF-b are also altered in emerin-null myogenic progenitors. mRNA expression of
selected downstream targets of the Wnt and TGF-b pathways was measured using qPCR. Dotted line represents no change in expression. A) Wnt
targets. B) TGF-b targets. All changes in gene expression were statistically significant (p#0.05).
doi:10.1371/journal.pone.0037262.g003
Figure 4. Expression of miRNAs was altered in emerin-null myogenic progenitors. miRNA expression was determined for emerin-null and
wildtype myogenic progenitors by microarray. miRNA expression in emerin-null myogenic progenitors was normalized to wildtype miRNA expression
in wildtype progenitors. Dotted line represents no change in expression. All changes in expression were statistically significant (p#0.05).
doi:10.1371/journal.pone.0037262.g004
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ingly, our mRNA microarray analysis showed Pax7 expression was
also increased 2.9-fold in emerin-null progenitors, suggesting that
the downregulation of p38 is physiologically relevant in emerin-
null myogenic progenitors.
Disrupted Protein Expression and Signaling in Emerin-
null Myogenic Progenitors
To test if IGF signaling was activated in emerin-null myogenic
progenitors, as predicted from expression profiling, proliferating
progenitors were incubated with 10 ng/ml recombinant IGF-1 for
10 minutes before harvesting. Cell lysates were separated by SDS-
PAGE and western blotted using antibodies specific for p38 or
phospho-p38. As expected, emerin-null myogenic progenitors
increased phospho-p38 levels 3.160.9-fold (Figure 6C). When
phospho-p38 levels are normalized to total p38, the emerin-null
myogenic progenitors increase total phospho-p38 two-fold in
response to IGF. Thus increased IGF binding protein expression
fails to completely compensate for increased expression of IGF-I,
IGF-II and the IGF receptors.
Collectively, these findings indicate that emerin-null myogenic
progenitors exhibit altered Wnt, TGF-b, Notch and IGF-1
signaling and predicts that emerin-null myogenic progenitors
exhibit enhanced proliferation and decreased differentiation
(Figure 7). Increased myoblast proliferation and decreased
differentiation and muscle regeneration was previously reported
for primary myoblasts derived from emerin-null mice [8]. This
study significantly advances our understanding of the molecular
mechanism underlying decreased muscle regeneration seen in
emerin-null mice.
Discussion
We report here major disruptions in the Notch, Wnt, TGF-b
and IGF pathways in myogenic progenitors derived from emerin-
null mice. Disruption of these pathways is predicted to cause
impaired myogenic differentiation (Figure 7). Previous studies
showed defective Rb signaling in skeletal muscle from EDMD
patients and emerin-null mice, which resulted in increased MyoD
expression and delayed myogenic differentiation and gene
expression [8,9]. However, this is the first report using genome-
wide expression profiling of mRNA and miRNA to identify and
begin interrogating broad signaling defects in emerin-null myo-
genic progenitors. Our data represent compelling evidence that
loss of a single nuclear envelope protein can have drastic
consequences on the expression of hundreds of genes, many of
which play important roles in myogenic differentiation and muscle
regeneration. With an ever-growing number of nuclear envelope
transmembrane proteins (NETs) being identified, it will be
essential to characterize their individual functions in detail and
determine their relative contributions to transcriptional and
signaling pathways.
Table 1. Selected miRs and their predicted targets, as determined by MicroCosm Targets.
miRNA Predicted Targets
miR-100 Fgf20, Fzd8, Hdac3, Myot, Smad7, Bmp3, Rbbp5
miR-132 Hdac3, Smad2, Wnt2, Gsk3a, Fgf21, Nup98, Mapk3, Wnt10a, Dll4
miR-183 Hdac11, Foxp1, Map2k1
miR-192 Ctcf, Myot, Wnt7a, Igf2, Rbpj, Mapk10, Serpine2
miR-195 Smad1, Fgf8, Wnt8a, Myo5b, Smad7, Smad2, Epha1, Mapk3, Fzd3
miR-199a-5p Map3k11, Foxp1, Unc45a, Fgf4, Igfbp2, Foxo4, Hdac2, Sirt1
miR-207 Map3k11, Lmnb1, Numbl, Map3k10, Ncor2, Igfbp2, Igfbp5, Inha, Map3k5, Igf1
miR-297a* Lmnb1, Nup98, Fgfr3, Epha5, Mapkapk2
miR-298 Igf1r, Igf1, Myf5, Mapk15, Itgb5, Map2k5, Adam15, Mapk13, Cdkn1a, Map3k3
miR-713 Epha1, Tgfa, Mapk14, Akt1
doi:10.1371/journal.pone.0037262.t001
Figure 5. miRNA-downregulation causes increased expression of target proteins. A) Whole cell lysate was separated by SDS-PAGE and
western-blotted for Myf5, Smad2 and c-tubulin. B,C) Densitometry was done on blots in panel A and Myf5 and Smad2 were normalized to c-tubulin.
Protein expression in wildtype myogenic progenitors was set to one.
doi:10.1371/journal.pone.0037262.g005
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Notch signaling maintains the undifferentiated state of satellite
cells [30] and a switch from Notch to Wnt signaling is necessary
for myogenic progenitors to begin differentiating and repair
damaged muscle tissue [30]. The increase in Notch signaling in
emerin-null progenitors may interfere with myogenesis by blocking
this transition and preventing the activation of quiescent satellite
cells in vivo. We predict the inability to activate sufficient numbers
of satellite cells in emerin-null skeletal muscle may result in
decreased numbers of proliferative myogenic progenitors and
myoblasts and contribute to the decreased regenerative potential
seen in EDMD.
Excessive canonical Wnt signaling negatively affects the
regenerative capacity of cultured satellite cells by converting them
to a fibrogenic lineage [31]. High levels of Wnt signaling were also
shown to increase fibrosis of aged skeletal muscle [31]. Wnt
signaling acts downstream of Notch signaling to promote
differentiation during adult myogenesis [30], and the Wnt effector
b-catenin promotes satellite cell to myotube progression [31]. With
a perturbation of the temporal switch from Notch to Wnt signaling
Figure 6. IGF signaling is activated in emerin-null myogenic progenitors. Protein expression of p38 and phosphorylated p38 in emerin-null
myogenic progenitors was monitored by western blotting (A) and quantitated by densitometry normalized to c-tubulin (B) or total p38 (C) levels in
wildtype progenitors. Antibodies specific for p38 (B) or phosphorylated p38 (C) were used to monitor activation of the IGF-1 pathway.
doi:10.1371/journal.pone.0037262.g006
Figure 7. Model of predicted effects of emerin loss on myogenic signaling during differentiation. A) Notch, Wnt, TGF-b and IGF signaling
act at specific times during myogenic differentiation to ensure proper differentiation. B) Our data predicts that activation of Notch and IGF-1 signaling
pathways and attenuation of Wnt and TGF-b signaling pathways will lead to impaired differentiation by maintaining the progenitors in a proliferative
state and exhausting the satellite cell niche.
doi:10.1371/journal.pone.0037262.g007
Myogenic Signaling in Emerin-Null Murine Myoblasts
PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e37262[30], we predict there is an increase in the pool of proliferating
myoblasts during differentiation of emerin-null myogenic progen-
itors. Based upon the decrease in Wnt signaling, we also predict an
impaired ability of emerin-null myogenic progenitors to differen-
tiate into committed myocytes and myotubes. We hypothesize that
increased myoblast proliferation and failure to differentiate
contributes to the impaired regeneration seen in EDMD.
TGF-b acts early in myogenesis to prevent activation of
promyogenic genes in satellite cells and to antagonize terminal
differentiation and fusion of myocytes to myotubes [14,56].
Aberrantly high TGF-b signaling was shown to interfere with
muscle regeneration by increasing phosphorylation of SMAD3 in
satellite cells and interfering with Notch activity [57]. TGF-b
signaling was downregulated in emerin-null myogenic progenitors.
Thus we predict that activation of satellite cells and myocyte cell
fusion to the damaged muscle fiber may be enhanced in skeletal
muscle lacking emerin. These effects are predicted to partially
mitigate the increased proliferation and block of differentiation
caused by increased Notch and Wnt signaling in emerin-null
myogenic progenitors. However, the degree to which downregu-
lation of TGF-b may mitigate the increased proliferation and
differentiation block of emerin-null progenitors remains to be
determined.
IGF signaling is mitogenic, as it promotes satellite cell
proliferation early in differentiation and promotes terminal
differentiation of myocytes during skeletal muscle regeneration
[58]. IGF signaling was enhanced in proliferative emerin-null
myoblasts and we predict that in emerin-null skeletal muscle
quiescent satellite cells are pushed towards an activated state,
thereby depleting the quiescent satellite cell niche. Further,
decreased TGF-b signaling is predicted to synergize with increased
IGF-1 signaling to deplete the pool of quiescent satellite cells. We
further predict increased fusion of myocytes to myotubes would
also been seen in emerin-null skeletal muscle. However, it will be
necessary to determine if perturbed IGF signaling persists at
similar levels during the entirety of myogenesis in emerin-null cells
to influence myocyte fusion.
p38 signaling was shown to inhibit the expression of Pax7 by
regulating the formation of the polycomb repressive complex 2
(PRC2) at the Pax7 promoter [54,55]. p38 phosphorylates the
EZH2 subunit of PRC2, which stabilizes the interaction between
PRC2 and the Pax7 promoter, resulting in promoter repression.
Pax7 confers myogenic lineage identity and is necessary for
maintenance of the satellite cell niche [59]. Pax7 also mediates the
initial activation of myogenic progenitor proliferation and thus is
an essential regulator of myogenic differentiation [55]. Emerin-
null myogenic progenitors have increased phospho-p38, suggesting
activation of phospho-p38 signaling, which is predicted to suppress
Pax7 expression and impair differentiation. This coupled to
decreased pro-myogenic Wnt signaling in emerin-null myogenic
progenitors suggests emerin-null myogenic progenitors have
increased proliferative potential and impaired differentiation into
committed myocytes. Loss of p38 also inhibits IGF-II expression
and impairs myoblast differentiation [60], which we predict
contributes to impaired regeneration in EDMD.
Collectively, perturbation of these signaling pathways may help
explain the relatively late onset (2
nd or 3
rd decade of life; [61]) of
skeletal muscle wasting seen in EDMD, since progressive loss of
the satellite cell niche is predicted to cause a relatively slow loss
of muscle regeneration over time. Additionally the pathogenesis
of the disease may occur slowly because increased or decreased
signaling in other partially redundant pathways may compensate
for defects in the signaling pathways above. This may also
explain why the dystrophic phenotype of EDMD tends to have a
later onset than other forms of muscular dystrophy.
Disrupted miRNA Expression
In several instances, such as miR-713, perturbed miRNA
expression appears to be related to the disrupted expression of
myogenic signaling components (e.g., p38). Several miRs that were
shown to play roles in muscle differentiation, including miR-1 and
miR-206, did not show disrupted expression in emerin-null
myogenic progenitors. While myomiR expression is driven by
myogenic regulatory factor expression, our studies do not show a
direct relationship between perturbed myogenic regulatory
signaling and disrupted expression of myomiRs in emerin-null
myogenic precursors. Though it is now possible to acquire
genome-wide miRNA expression data, the complexity of interac-
tions between many miRs that target a single transcript, as well as
the hundreds of transcripts that are targeted by a single miR make
the annotation and validation of miR targeting an important goal
for the future. Future studies will also analyze how changes in
expression of miRs in emerin-null myogenic progenitors affect cell
signaling and transcriptional pathways important for myogenic
differentiation and skeletal muscle regeneration.
Now that we have identified perturbations of the Notch, Wnt,
TGF-b and IGF pathways in emerin-null myogenic progenitors, it
will be important to test if impaired signaling persists during
differentiation of emerin-null progenitors. It will also be important
to determine the relative contributions of each signaling pathway
to the impaired differentiation and muscle regeneration seen in
emerin-null myogenic progenitors. Further studies also need to
examine whether using pharmacological inhibitors or activators of
these important myogenic signaling pathways are able to restore
normal signaling pathway function in emerin-null myogenic
progenitors. These compounds would then be candidates for
treating the impaired muscle regeneration in emerin-null mice and
EDMD patients. Using this approach we predict potential drugs
will be identified to treat EDMD patients.
Materials and Methods
Myogenic Progenitor Isolation and Cell Culture
Wildtype and Emerin-null H2K mouse myogenic progenitors
were a generous gift from Tatiana Cohen and Terry Partridge
(Children’s National Medical Center, Washington, DC). Emerin-
null H2K mice were generated by Tatiana Cohen and Terry
Partridge by breeding emerin-null and H-2K
btsA58 mice [51,52].
Myogenic progenitors were isolated and maintained as previously
described [52,53]. Briefly, extensor digitorum longus (EDL)
muscles were isolated and placed into 2 mg/ml collagenase
(Sigma, product #C0130) in DMEM (Invitrogen, product
#11995-065) for 1–2 hours at 35uC. Individual fibers were then
isolated and each fiber was transferred serially through 2–4 petri
dishes containing DMEM to select for undamaged fibers. Fibers
were placed into matrigel-coated petri dishes containing DMEM,
10% horse serum (Invitrogen product #16050-098), 0.5% chick
embryo extract (Accurate Chemical, product #CE6507), 2% L-
Glutamine (Invitrogen, product #25030-081) and 1% penicillin/
streptomycin (Invitrogen, product #15140-122) for 3–4 hours at
37uC. Myogenic progenitors were isolated from individual fibers
by transferring each fiber into one matrigel-coated well of a 24-
well plate containing proliferation media consisting of DMEM,
20% Heat inactivated FBS (Invitrogen, product #10082-147), 2%
chick embryo extract, 2% L-glutamine, 1% pen-strep and 20 ng/
ml c-Interferon (Millipore, product #IF005). The fibers were
incubated for 24–48 hours at 33uC, 10% CO2. Upon attachment
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and the myogenic progenitor was incubated in proliferation media
for another 48 hours at 33uC, 10% CO2. Approximately 200 cells
are expected after 48 hours and these were split and proliferated
until enough cells were obtained for our analyses. H2K myogenic
progenitors were maintained in proliferation media at 33uC and
10% CO2. Cells between passages 4–10 were used for these
studies.
Genome-wide Expression
Total RNA was isolated from 500,000 sub-confluent prolifer-
ative wildtype or emerin-null H2Ks using the miRNeasy Mini Kit
(Qiagen, product #217004) and processed according to manu-
facturer’s protocol. RNA was isolated from two independent cell
culture plates for each replicate to determine significant changes in
mRNA and miRNA expression. Each isolated RNA sample was
then hybridized to GeneChip Mouse Genome 430 2.0 Arrays
(Affymetrix) at the University of Chicago Functional Genomics
Facility. The Affymetrix statistical software suite was used for
statistical analysis using Robust Multichip Analysis at the
Functional Genomics Facility to identify significant differences
between both samples. To identify changes in miRNA expression
1 ug of total RNA was hybridized to GeneChip miRNA Arrays
(Affymetrix) and processed at the University of Chicago Functional
Genomics Facility. Principal component analysis was performed
on the samples and the two conditions segregated into two
independent and defined groups. Statistical analysis using Robust
Multichip Analysis was performed by the Functional Genomics
Facility to identify significant differences between both samples.
The microarray data is MIAME compliant and is available
through the NCBI Gene Expression Omnibus, accessible through
GEO accession numbers GSM787505-GSM787512. Selected
mRNA levels were confirmed by qPCR, as described below.
qPCR
Total RNA was prepared as above and cDNA was generated
from RNA using MMLV Reverse Transcriptase (Invitrogen,
product # 28025013) per manufacturer instructions for individual
qPCRs. For qPCR arrays, cDNA was generated using the RT
2
First Strand Kit (SABiosciences, product #C-03). qPCR was
performed using a combination of individual primer sets (see
Table 2 for sequences of primers used and SYBR GreenER qPCR
SuperMix (Invitrogen, product #11761-500). RT
2 Profiler PCR
arrays were also used for the Mouse Wnt (SABiosciences, product
#PAMM-043A-2) and TGF-b/BMP (SABiosciences, product
#PAMM-035A-2) pathways using RT
2 Real-Time SYBR
Green/fluorescein PCR master mix (SABiosciences, product
#PA-011).
Emerin Rescue of Gsk3b, Mapk14 and Igfbp3 Expression
pEGFP (Clontech) or pEGFP-emerin was electroporated into 2
million emerin-null myogenic progenitors using the Neon trans-
fection system (Invitrogen) with 2 pulses of 1225 volts at a width of
30 milliseconds. The electroporated progenitors were plated in
separate 150 mm plates and incubated at 33uC, 10% CO2. After
16–48 hours Fluorescence Activated Cell Sorting selected GFP or
GFP-emerin expressing cells. On average 120,000 GFP-positive
cells were received per electroporation. RNA was isolated and
cDNA was generated as previously described. Gsk3b, Mapk14,
Igfbp3 and Gapdh mRNA expression was monitored using qPCR.
Gsk3b, Mapk14 and Igfbp3 levels in GFP or GFP-emerin expressing
myogenic progenitors were normalized to Gapdh expression. Gsk3b,
Mapk14 and Igfbp3 expression in GFP expressing progenitors is set
to one and Gsk3b, Mapk14 and Igfbp3 expression is plotted as fold-
change of GFP-emerin expressing progenitors as compared to
GFP expressing progenitors.
Table 2. List of qRT-PCR primers used in this study.
Gene Forward (59-39) Reverse (59-39)
Bmp1 GCCATCCATCAAAGCTGCAGGAAA TCCCTCCAATCACAAACGGGATGA
Ccnd1 ATTGGTCTTTCATTGGGCAACGGG GGCCAATTGGGTTGGGAAAGTCAA
Cdkn1b AGAAATCTCTTCGGCCCGGTCAAT TTGCGCTGACTCGCTTCTTCCATA
Crebbp TTGTGATTCATCTGCATGCTGGGC ATTTGGAGCGGCGTAAGGAAGAGA
Ep300 AGCACACACAGCTGATCCAGAGAA CGCTGGCACTTGTGAGCATGTAAA
Foxo1 ACATTTCGTCCTCGAACCAGCTCA ATTTCAGACAGACTGGGCAGCGTA
Fzd7 GGAACGCATTCACACACACACACA AACCTCGGATTTCTGTGGCTTTGC
Gapdh AACATTGGCATTGTGGAAGGGCTC TGGAAGAGTGGGAGTTGCTGTTGA
Gsk3b TCCGAGGAGAGCCCAATGTTTCAT TGGACGTGTAATCAGTGGCTCCAA
Igf1 AAGCAAGAGGCTAGGGATTTGGGA ATTTGACTGAGGTCACAGGGTGGT
Igfbp3 TGATTTCAGACGTTCCGTGGCTGA AAGTAGATCAGGCCACTTGCGGAT
Igfbp5 ACGGCGAGCAAACCAAGATAGAGA TCAGCTTCTTTCTGCGGTCCTTCT
Kat2b TACCTCTTCACCTGCGTCCACAAA TCACACCCTGTTCAATACTGGGCT
Mapk14 AAGCTCTTGCGCATGCCTACTTTG AACAGAAACCAGGTGCTCAGGACT
Mapkapk3 TTTGTGAAAGGTCGCACTTGGCTC AACCCTCTCTGCTCCAATTCTGCT
Rbpj CCTTGTTACCAAACAGGTTGCGCT TGGTGAGGCTCGAACCTGAATGAA
Tgfbr1 TGTCAAAGTCAGTCCGTTGGGTCT ACTTTGAAAGCCACACAAGCCCTG
Tgfbr2 AGATGGCTCGCTGAACACTACCAA AGAATCCTGCTGCCTCTGGTCTTT
Tgfbr3 AGCACATTGGAGAGACGACCACTT AGGCTCATCAGAAAGGCTGATGGT
Wnt4 GCAGATGTGCAAACGGAACCTTGA ACACCTGCTGAAGAGATGGCGTAT
doi:10.1371/journal.pone.0037262.t002
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Misregulated miRNAs were entered into Microcosm Targets,
an online repository of predicted and validated targets of all
miRBase-annotated miRNAs. Targets of interest within the Wnt,
TGF-b, IGF-1, and Notch pathways were selected based on their
involvement in myogenesis or nuclear envelope structure and
function.
Western Blotting
H2K cells were grown under proliferative conditions as
described. Wildtype and emerin-null cells were treated with
12.5 ng/ml IGF-1 (Millipore, product #GF138) for 10 minutes.
Cells were collected and resuspended in NuPAGE LDS Sample
Buffer (Invitrogen, product #NP0007) containing 14 mM b-
mercaptoethanol (Sigma, product #M3148) at a concentration
of 10
7 cells/ml. An equal number of wildtype and emerin-null cells
was separated by electrophoresis on NuPAGE 4-12% Bis-Tris
Gels (Invitrogen, product # NP0323BOX), and transferred to
nitrocellulose membranes. Membranes were blocked for 1 hour in
3% BSA in phosphate buffered saline (PBS) containing 0.1%
Tween 20 (PBS-T) followed by incubation for 2 hours at room
temperature or overnight with the indicated primary antibodies.
Antibodies used were against p38 (Cell Signaling, product #
9212), phospho-p38 (Cell Signaling, product # 4511S), Kat2b
(Abcam, product # ab12188), GSK3b (Cell signaling, product #
9315), Smad2 (Cell Signaling, product # 3102), Myf5 (Abcam,
product # ab69997), and c-tubulin (Sigma, product # T6557) in
3% BSA in PBS-T. Membranes were washed 5 times in PBS-T
and placed in appropriate secondary antibody (Thermo Scientific,
goat anti-mouse product # 31430, goat anti-rabbit product #
31460) at a concentration of 1:10,000 for 2 hours at room
temperature. Antibody binding was assayed using ECL chemilu-
minescence detection reagent (GE healthcare, product #
RPN2106V1 and RPN2106V2). Images were scanned and band
intensities were determined using Quantity One software (Bio-
Rad).
Supporting Information
Figure S1 Ingenuity Systems analysis to identify effect
of emerin loss on IGF-1 signaling pathway. The network
was generated through the use of IPA (Ingenuity Systems, www.
ingenuity.com) on normalized mRNA values. Nodes represent
molecules in a pathway, while the biological relationship between
nodes is represented by a line (edge). Edges are supported by at
least one reference in the Ingenuity Knowledge Base. The
intensity of color in a node indicates the degree of up- (red) or
down- (green) regulation. Nodes are displayed using shapes that
represent the functional class of a gene product (Circle= Other,
Nested Circle= Group or Complex, Rhombus= Peptidase,
Square= Cytokine, Triangle= Kinase, Vertical ellipse= Trans-
membrane receptor). Edges are marked with symbols to represent
the relationship between nodes (Line only= Binding only, Flat
line= inhibits, Solid arrow = Acts on, Solid arrow with flat line=
inhibits and acts on, Open circle= leads to, Open arrow=
translocates to).
(TIF)
Figure S2 Ingenuity Systems analysis to identify effect
of emerin loss on Notch signaling pathway. The network
was generated through the use of IPA (Ingenuity Systems, www.
ingenuity.com) on normalized mRNA values. Nodes represent
molecules in a pathway, while the biological relationship between
nodes is represented by a line (edge). Edges are supported by at
least one reference in the Ingenuity Knowledge Base. The
intensity of color in a node indicates the degree of up- (red) or
down- (green) regulation. Nodes are displayed using shapes that
represent the functional class of a gene product (Circle= Other,
Nested Circle= Group or Complex, Rhombus= Peptidase,
Square= Cytokine, Triangle= Kinase, Vertical ellipse= Trans-
membrane receptor). Edges are marked with symbols to represent
the relationship between nodes (Line only= Binding only, Flat
line= inhibits, Solid arrow = Acts on, Solid arrow with flat line=
inhibits and acts on, Open circle= leads to, Open arrow=
translocates to).
(TIF)
Figure S3 Ingenuity Systems analysis to identify effect
of emerin loss on Wnt/b-catenin signaling pathway. The
network was generated through the use of IPA (Ingenuity Systems,
www.ingenuity.com) on normalized mRNA values. Nodes repre-
sent molecules in a pathway, while the biological relationship
between nodes is represented by a line (edge). Edges are supported
by at least one reference in the Ingenuity Knowledge Base. The
intensity of color in a node indicates the degree of up- (red) or
down- (green) regulation. Nodes are displayed using shapes that
represent the functional class of a gene product (Circle= Other,
Nested Circle= Group or Complex, Rhombus= Peptidase,
Square= Cytokine, Triangle= Kinase, Vertical ellipse= Trans-
membrane receptor). Edges are marked with symbols to represent
the relationship between nodes (Line only= Binding only, Flat
line= inhibits, Solid arrow = Acts on, Solid arrow with flat line=
inhibits and acts on, Open circle= leads to, Open arrow=
translocates to).
(TIF)
Figure S4 Ingenuity Systems analysis to identify effect
of emerin loss on TGF-b signaling pathway. The network
was generated through the use of IPA (Ingenuity Systems, www.
ingenuity.com) on normalized mRNA values. Nodes represent
molecules in a pathway, while the biological relationship between
nodes is represented by a line (edge). Edges are supported by at
least one reference in the Ingenuity Knowledge Base. The
intensity of color in a node indicates the degree of up- (red) or
down- (green) regulation. Nodes are displayed using shapes that
represent the functional class of a gene product (Circle= Other,
Nested Circle= Group or Complex, Rhombus= Peptidase,
Square= Cytokine, Triangle= Kinase, Vertical ellipse= Trans-
membrane receptor). Edges are marked with symbols to represent
the relationship between nodes (Line only= Binding only, Flat
line= inhibits, Solid arrow = Acts on, Solid arrow with flat line=
inhibits and acts on, Open circle= leads to, Open arrow=
translocates to).
(TIF)
Figure S5 Protein expression is similar between prima-
ry myoblasts and H2K myoblasts. A) Whole cell lysate from
primary myoblasts and H2K myogenic progenitors were separated
by SDS-PAGE and western-blotted for Kat2b, GSK3b, Myf5 and
c-tubulin. B) Densitometry was performed on blots in panel A to
measure protein expression. Kat2b, GSK3b and Myf5 densitom-
etry were normalized to c-tubulin for each sample.
(TIF)
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